These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 95412)

  • 1. Isoprinosine as an immunopotentiator.
    Renoux G; Renoux M; Guillaumin JM
    J Immunopharmacol; 1979; 1(3):337-56. PubMed ID: 95412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of two immunopotentiators, Isoprinosine and NPT 15392, on murine T-cell differentiation and function.
    Ikehara S; Hadden JW; Good RA; Lunzer DG; Pahwa RN
    Thymus; 1981 Aug; 3(2):87-95. PubMed ID: 6170135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation.
    Hadden JW; Hadden EM; Coffey RG
    Infect Immun; 1976 Feb; 13(2):382-7. PubMed ID: 57100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions.
    Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I
    J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selectivity of isoprinosine, NPT 15392, avridine and cyclophosphamide on multiple immune responses in rats.
    Exon JH; Henningsen GM; Koller LD; Talcott PA
    Int J Immunopharmacol; 1986; 8(1):53-62. PubMed ID: 2420733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprinosine enhances PHA responses and has potential effect on natural killer cell (NK) activity of uremic patients in vitro.
    Silvennoinen-Kassinen S; Karttunen R; Tiilikainen A; Huttunen K
    Nephron; 1987; 46(3):243-6. PubMed ID: 2442634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
    Morin A; Griscelli C; Daguillard F
    Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM
    Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of isoprinosine in animal models of depressed T-cell function.
    Binderup L
    Int J Immunopharmacol; 1985; 7(1):93-101. PubMed ID: 2581907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM
    Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of isoprinosine on in vitro proliferative responses of human lymphocytes stimulated by antigen.
    Ballet JJ; Morin A; Schmitt C; Agrapart M
    Int J Immunopharmacol; 1982; 4(3):151-7. PubMed ID: 6179890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human T lymphocyte functions by isoprinosine.
    Rey A; Cupissol D; Thierry C; Esteve C; Serrou B
    Int J Immunopharmacol; 1983; 5(1):99-103. PubMed ID: 6188707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of isoprinosine on the PHA response of monocyte-depleted and undepleted peripheral blood mononuclear cells.
    Jacobsen PL; Greenspan JS
    J Immunopharmacol; 1982-1983; 4(4):355-65. PubMed ID: 6192176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprinosine as an immunopotentiator in an animal model of human osteosarcoma.
    Tsang KY; Fudenberg HH
    Int J Immunopharmacol; 1981; 3(4):383-9. PubMed ID: 6174468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopharmacology of the hypoxanthine containing compounds isoprinosine and NPT 15392.
    O'Neill BB; Ginsberg T; Hadden J
    Prog Clin Biol Res; 1984; 161():525-41. PubMed ID: 6207547
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunostimulating properties of the complexes of inosine derivatives.
    Poluektova L; Maurinsh Y; Lidaks M; Gromova N
    Int J Immunopharmacol; 1995 Nov; 17(11):941-7. PubMed ID: 8788123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum levels of IgG and IgA in rabbits immunostimulated with naganol and isoprinosine].
    Stoev K; Toshkov A; Georgiev D
    Acta Microbiol Bulg; 1984; 14():116-9. PubMed ID: 6204509
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppressor cell activity after isoprinosine treatment of lymphocytes from normal mice.
    Renoux G; Renoux M; Degenne D
    Int J Immunopharmacol; 1979; 1(3):239-41. PubMed ID: 95251
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production.
    Wiranowska-Stewart M; Hadden JW
    Int J Immunopharmacol; 1986; 8(1):63-9. PubMed ID: 2420734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprinosine increases the antitumor action of interferon.
    Cerutti I; Chany C; Schlumberger JF
    Int J Immunopharmacol; 1979; 1(1):59-63. PubMed ID: 95187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.